Volume 422

Main
Cancer Letters
Volume 422

Cancer Letters

Volume 422

1

ICAM3 mediates inflammatory signaling to promote cancer cell stemness

Shen, Wenzhi, Xie, Junling, Zhao, Shuangtao, Du, Renle, Luo, Xiaohe, He, Huiwen, Jiang, Shan, Hao, Na, Chen, Chong, Guo, Chunlei, Liu, Yanhua, Chen, Yanan, Sun, Peiqing, Yang, Shengyong, Luo, Na, Xian

Journal:

Year:

2018

Language:

english

File:

PDF, 7.47 MB

english, 2018

2

Retraction notice to “SRI36160 is a specific inhibitor of Wnt/-catenin signaling in human pancreatic and colorectal cancer cells” [Canc. Lett. 389C (2017) 41–48]

Li, Yonghe, Oliver, Patsy G., Lu, Wenyan, Pathak, Vibha, Sridharan, Sivaram, Augelli-Szafran, Corinne E., Buchsbaum, Donald J., Suto, Mark J.

Journal:

Year:

2018

Language:

english

File:

PDF, 164 KB

english, 2018

3

Retraction notice to “A novel class of specific Hsp90 small molecule inhibitors demonstrate in vitro and in vivo anti-tumor activity in human melanoma cells”

Mehta, Pramod P., Kung, Pei-Pei, Yamazaki, Shinji, Walls, Marlena, Shen, Andrea, Nguyen, Leslie, Gehring, Michael R., Los, Gerrit, Smeal, Tod, Yin, Min-Jean

Journal:

Year:

2018

Language:

english

File:

PDF, 158 KB

english, 2018

4

Retraction notice to “MiR-143 inhibits tumor cell proliferation and invasion by targeting STAT3 in esophageal squamous cell carcinoma”

Liu, Jia, Mao, Yu, Zhang, Dakai, Hao, Shengnan, Zhang, Zicheng, Li, Zhenjiang, Li, Baosheng

Journal:

Year:

2018

Language:

english

File:

PDF, 161 KB

english, 2018

5

Editorial Board

Journal:

Year:

2018

File:

PDF, 27 KB

2018